Brixmor (BRX) Form 144: 25,000 RSU-derived shares to be sold via UBS

Rhea-AI Filing Summary

Brixmor Property Group reported a proposed insider sale under Rule 144 for 25,000 common shares, to be executed through UBS Financial Services on 09/05/2025 on the NYSE at an aggregate market value of $706,250. The shares were acquired as restricted stock units on 01/01/2024 and fully paid at acquisition. The filing states there were no other securities sold by the reporting person in the past three months. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

• Transparent compliance with Rule 144 via brokered sale and explicit representation of no undisclosed material adverse information
• Transaction sourced from RSUs, indicating shares originated from compensation rather than external purchase

Negative

• Insider sale disclosed—25,000 shares will be sold, which may prompt investor questions about insider liquidity needs

Insights

Financial Analyst

TL;DR: An insider plans a modest Rule 144 sale of 25,000 shares (about 0.008% of shares outstanding), a routine liquidity event with limited market impact.

The filing shows a planned sale of 25,000 common shares via UBS with an aggregate value of $706,250 and indicates acquisition as RSUs on 01/01/2024. Relative to the reported shares outstanding of 306,099,542, the block is immaterial to capitalization and unlikely to move the stock price by itself. The absence of other sales in the prior three months and the explicit representation of no undisclosed material adverse information reduce immediate governance concerns. This is a standard disclosure under Rule 144 to comply with resale restrictions.

Corporate Governance Expert

TL;DR: The filing is compliant and procedural; insider sale appears routine, but investors may note timing and size relative to insider compensation.

The document identifies the transaction as the sale of RSU-derived shares through a registered broker on a specified date, with no prior sales reported in the last three months. That transparency aligns with good disclosure practices. There is no indication of adverse corporate developments in the filing. Governance stakeholders would typically monitor aggregate insider sales over time, but this single Form 144 is a commonplace liquidity event tied to equity compensation.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	25000	706250	306099542	09/05/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2024	RSU	Issuer			25000	01/01/2024	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did BRX disclose in the Form 144 filing?

The filer disclosed a proposed sale of 25,000 common shares via UBS on 09/05/2025 with an aggregate market value of $706,250.

How were the shares being sold acquired?

The shares were acquired as restricted stock units (RSUs) on 01/01/2024 and were fully paid at acquisition.

Does the filing report other sales in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months by the reporting person.

Through which broker will the shares be sold?

The sale is planned through UBS Financial Services Inc. on the NYSE.

How large is the sale relative to outstanding shares?

The filing lists 306,099,542 shares outstanding; the 25,000-share sale represents a very small fraction of total shares outstanding.